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Introduction
Caesarean scar ectopic pregnancy (CSEP) is a rare
occurrence in pregnancy, it’s presentation warrants
emergent care. While it is the rarest form of ectopic
pregnancy, (1:1,800-1:2,216 of all pregnancies), the
incidence is increasing (Rotas et al, 2006). This
early study highlighted that the increase is most
likely due to the growing number of caesareans
being performed. In CSEP, the gestational sac (GS)
is implanted within the myometrium of a previous
caesarean section scar (Rana et al, 2013).
This poster discusses a case where the patient
initially presented to the Accident and Emergency
Department (A+E), with lower abdominal pain. An
overview of her case will be outlined, from initial
assessment, diagnosis and management to
complete resolution. This case highlights the integral
role of the transvaginal ultrasound scan (TVS) in
conjunction with serial biochemistry in the
management of CSEP. Serial biochemistry involves
monitoring the pregnancy hormone human chorionic
gonadotrophin (hCG).
Fig 4 over, demonstrates the ongoing intrauterine
changes.
Monitoring by TVS over a lengthy twenty week
period, continued to demonstrate minimal changes,
further supported by a reduction in hCG levels as
displayed in Fig.5. below.
Interestingly, at twenty weeks post MTX, with a hCG
of 2, a sonolucent area at the LSCS scar site
persisted, see Fig.6.
A final TVS, at eight months post treatment,
demonstrated a non-pregnant uterus. However, a
calcified GS was present at the LSCS scar site, see
Fig.7.
Patient Background
A 37 year old lady, Para 3+0 presented to the A+E,
with a three hour history of acute onset, severe
abdominal pain. She had a history of having 2
spontaneous vaginal deliveries and one elective
lower uterine caesarean section for a breech
presentation. Her last menstrual period (LMP) and
serum hCG levels suggested that she was
approximately 6 weeks gestation. A prompt referral
was made to the Early Pregnancy Unit for
assessment.
Ultrasound Examination
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Figure 3: TVS showing CSEP four weeks post MTX
.
Figure 1: TVS longitudinal view of the abnormal implantation of the IUGS
.
TV Ultrasound Scan
Figure 4: TVS seven weeks post Methotrexate. hCG 61 miu/l  
Colour Doppler was applied to assess for the
presence of vascularity (Fig 2) around the ectopic
trophoblast (Honemeyer et al, 2013). The presence
of this ‘ring of fire’ aides in the diagnosis of ectopic
pregnancy. This modality was also employed to
confirm the absence of cardiac activity.
Repeat scans confirmed no change and a CSEP
was diagnosed.
Treatment
A STAT dose of Mifepristone 600mgs was
administered prior to the initial dose of
Methotrexate (MTX). The combination is
considered a potentially therapeutic treatment for
CSEP (Gómez García et al, 2015). The MTX was
repeated as per the HSE guidelines (2014) when
the hCG levels failed to decrease by the desired
15% between day four and seven.
Methotrexate is a folic acid antagonist and works
through inhibiting the proliferation of trophoblastic
cells (HSE, 2014). It is cost effective and avoids the
need for surgical intervention. Medical
management was deemed the most prudent
management option, minimising the risk of potential
morbidity.
Follow-up Ultrasounds
A follow-up ultrasound at one month post repeat
Methotrexate (MTX) demonstrates a thinner ET of
4.68mm. The GS has become more irregular in
shape, yet remains clearly identifiable, as illustrated
in Fig 3. The hCG is 381miu/l at this stage.
hCG Trend
Figure 5: Graphic illustration of serial serum hCG from diagnosis to 
resolution.
Figure 6: Longitudinal view of CSEP at twenty weeks  post MTX, hCG 2 
miu/l
Figure 7: A calcified gestational sac in LSCS scar tissue. 
Conclusion
Interestingly, at twenty weeks post MTX, with a 
hCG of 2 miu/l, a sonolucent area persisted at the 
LSCS scar site (Fig 6).
A final TVS at eight months post treatment 
demonstrated a non-pregnant uterus. However, a 
calcified GS was present at the LSCS scar site as 
seen in Fig 7 (marked by the yellow arrow).
Figure 2: Colour Doppler demonstrates trophoblastic 
neovascularisation encircling the GS.                                                                                      
Initially, a transabdominal ultrasound scan (TAS)
was performed. This afforded only limited views of
the uterus as the bladder was empty. We proceeded
to a transvaginal ultrasound scan (TVS).
While the TVS revealed an anteverted uterus and
the familiar sonolucent, circular gestational sac (GS)
was observed, it was readily identifiable due to the
presence of a hyperechoic, circular yolk sac (YS),
and an embryo was present. The crown-rump-
length (CRL) was 3.3mm, and the mean GS
diameter was 14.98mm. It appeared to be
abnormally implanted adjacent to the more
echogenic scar tissue of a previous caesarean scar.
The endometrial thickness (ET) nearer the fundus
was 15.5mm, (Fig1). The ovaries and adnexa
appeared normal. The hCG was 13399 miu/l.
